Hartmut Stocker

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients
    Hartmut Stocker
    HIV Lab, Haus 30, c o Vivantes Auguste Viktoria Klinikum, Rubensstrasse 125, 12157 Berlin, Germany
    Antimicrob Agents Chemother 48:4148-53. 2004
  2. ncbi Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration
    Hartmut Stocker
    Vivantes Auguste Viktoria Klinikum, Rubensstrasse 125, 12157 Berlin, Germany
    J Antimicrob Chemother 59:560-4. 2007
  3. ncbi Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings
    Hartmut Stocker
    Vivantes Auguste Viktoria Klinikum, Kompetenznetz HIV AIDS Deutschland, Rubensstrasse 125, 12157 Berlin, Germany
    Antimicrob Agents Chemother 50:667-73. 2006
  4. ncbi Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors
    Keikawus Arasteh
    Vivantes Auguste Viktoria Klinikum, Klinik fur Innere Medizin, Infektiologie Gastroenterologie, Rubensstr 125, 12157 Berlin, Germany
    Eur J Med Res 12:397-402. 2007
  5. ncbi A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy
    Nils von Hentig
    Pharmazentrum Frankfurt at the JW Goethe University, Frankfurt, Germany
    Br J Clin Pharmacol 62:552-9. 2006
  6. ncbi The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients
    Guido Kruse
    Therapia GmbH, Berlin, Germany
    Antivir Ther 10:349-55. 2005
  7. ncbi Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir
    Michael Kurowski
    Therapia GmbH, Berlin, Germany
    AIDS 21:1368-70. 2007
  8. ncbi Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy
    Hubert Schulbin
    Medizinische Klinik I, Charite, Campus Benjamin Franklin, Berlin, Germany
    Antimicrob Agents Chemother 52:3377-84. 2008

Collaborators

Detail Information

Publications8

  1. ncbi Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients
    Hartmut Stocker
    HIV Lab, Haus 30, c o Vivantes Auguste Viktoria Klinikum, Rubensstrasse 125, 12157 Berlin, Germany
    Antimicrob Agents Chemother 48:4148-53. 2004
    ..The AUC of EDDP increased significantly, by 35%. Methadone dose adjustments are justified when methadone is coadministered with nevirapine. Due to extensive variability, the adjustments must be tailored to the individual patient's needs...
  2. ncbi Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration
    Hartmut Stocker
    Vivantes Auguste Viktoria Klinikum, Rubensstrasse 125, 12157 Berlin, Germany
    J Antimicrob Chemother 59:560-4. 2007
    ..This study evaluated the steady-state pharmacokinetic interaction between ritonavir-boosted saquinavir and nelfinavir...
  3. ncbi Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings
    Hartmut Stocker
    Vivantes Auguste Viktoria Klinikum, Kompetenznetz HIV AIDS Deutschland, Rubensstrasse 125, 12157 Berlin, Germany
    Antimicrob Agents Chemother 50:667-73. 2006
    ..Many patients may achieve insufficient concentrations. Further covariate analysis in the population PK model might help to identify factors influencing the variability in ENF concentrations...
  4. ncbi Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors
    Keikawus Arasteh
    Vivantes Auguste Viktoria Klinikum, Klinik fur Innere Medizin, Infektiologie Gastroenterologie, Rubensstr 125, 12157 Berlin, Germany
    Eur J Med Res 12:397-402. 2007
    ..This article presents and discusses available data on viral tropism and tropism testing in the context of CCR5 inhibitor treatment...
  5. ncbi A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy
    Nils von Hentig
    Pharmazentrum Frankfurt at the JW Goethe University, Frankfurt, Germany
    Br J Clin Pharmacol 62:552-9. 2006
    ....
  6. ncbi The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients
    Guido Kruse
    Therapia GmbH, Berlin, Germany
    Antivir Ther 10:349-55. 2005
    ..No serious adverse events occurred through the study period. CONCLUSION: Nelfinavir does not require dose adjustment when coadministered with tenofovir and appears to be well-tolerated by HIV-infected patients...
  7. ncbi Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir
    Michael Kurowski
    Therapia GmbH, Berlin, Germany
    AIDS 21:1368-70. 2007
    ....
  8. ncbi Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy
    Hubert Schulbin
    Medizinische Klinik I, Charite, Campus Benjamin Franklin, Berlin, Germany
    Antimicrob Agents Chemother 52:3377-84. 2008
    ..Despite reductions in levels of mucosal HIV RNA and the restoration of mucosal CD4(+) T lymphocytes, antiretroviral therapy failed to restore the normal colonic immunologic environment...